Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer.

Karamitopoulou E, Haemmig S, Baumgartner U, Schlup C, Wartenberg M, Vassella E.

Mod Pathol. 2017 Aug;30(8):1116-1125. doi: 10.1038/modpathol.2017.35. Epub 2017 May 26.

2.

PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential.

Wartenberg M, Centeno I, Haemmig S, Vassella E, Zlobec I, Galván JA, Neuenschwander M, Schlup C, Gloor B, Lugli A, Perren A, Karamitopoulou E.

Eur J Cancer. 2016 Sep;65:80-90. doi: 10.1016/j.ejca.2016.06.013. Epub 2016 Jul 29.

PMID:
27475963
3.

miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers.

Langsch S, Baumgartner U, Haemmig S, Schlup C, Schäfer SC, Berezowska S, Rieger G, Dorn P, Tschan MP, Vassella E.

Cancer Res. 2016 Jul 15;76(14):4160-9. doi: 10.1158/0008-5472.CAN-15-2580. Epub 2016 May 19. Erratum in: Cancer Res. 2016 Nov 1;76(21):6436.

4.

Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type?

Vassella E, Langsch S, Dettmer MS, Schlup C, Neuenschwander M, Frattini M, Gugger M, Schäfer SC.

Oncotarget. 2015 Sep 15;6(27):23905-16.

5.

In vitro and in vivo evaluation of an innocuous drug cocktail to improve the quality of folic acid targeted nuclear imaging in preclinical research.

Müller C, Reber J, Schlup C, Leamon CP, Schibli R.

Mol Pharm. 2013 Mar 4;10(3):967-74. doi: 10.1021/mp300428p. Epub 2013 Feb 8.

PMID:
23394590

Supplemental Content

Loading ...
Support Center